Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART) [Phase 3]

View source ↗

Summary

Phase 3 ESPART trial evaluating the efficacy and safety of Pergoveris in assisted reproductive technology for infertility has completed. Results were posted Jan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Pergoveris (follitropin alfa and lutropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Phase 3 | Status: COMPLETED | Results posted: 2017-01-24